Eighty-seven percent said more pharmaceutical options for the disease are needed, while 62% said such devices as insulin pumps, monitors and implants, as well as drug therapies, are most likely to have the greatest near-term benefit to patients.???At the same time, there were significant differences between the responses of physicians and delegates to the conference.